Sec. 30. Reimbursement status as undue inducement.
73 words·~1 min read·
/il/chapter-410/act-416/30A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Sec. 30. Reimbursement status as undue inducement. Reimbursement of ancillary costs incurred by a subject under the program:
(1)does not constitute an undue inducement to participate in a clinical trial;
(2)is not considered coercion or the exertion of undue influence to participate in a
clinical trial; and
(3)shall be deemed to accomplish parity in access to clinical trials and remove
barriers to participation in clinical trials for financially burdened subjects.